NCT00579813View on ClinicalTrials.gov

Mechanisms Underlying Metabolic Syndrome in Obesity

PHASE4CompletedINTERVENTIONAL
Enrollment

70

Participants

Timeline

Start Date

April 30, 2005

Primary Completion Date

January 31, 2009

Study Completion Date

January 31, 2011

Conditions
Metabolic SyndromeInsulin ResistancePrediabetes
Interventions
DRUG

Pioglitazone

Pioglitazone 30mg for 2 weeks, then Pioglitazone 45mg for 8 weeks.

Trial Locations (2)

40536

University of Kentucky, Lexington

72205

University of Arkansas for Medical Sciences, Little Rock

All Listed Sponsors
collaborator

National Institutes of Health (NIH)

NIH

collaborator

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

NIH

lead

Philip Kern

OTHER

NCT00579813 - Mechanisms Underlying Metabolic Syndrome in Obesity | Biotech Hunter | Biotech Hunter